Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Disruption of Wnt/β-Catenin Signaling Exerts Antileukemia Activity and Sensitizes with Tyrosine Kinase Inhibitors in FLT3 Mutated AML In Vivo

Xuejie Jiang, Po Yee Mak, MPhil, Hong Mu, MD PhD, Duncan Mak, BSc, MPhil, Qi Zhang, MD PhD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD, Bing Z Carter, PhD

Blood (2016) 128 (22): 2828.

https://doi.org/10.1182/blood.V128.22.2828.2828

Published: 2016

Journal Articles

Inhibition of FAK Exerts Anti-Leukemic Activity and Potentiates ABT-199-Induced Apoptosis in AML

Xiangmeng Wang, Po Yee Mak, MPhil, Hong Mu, MD PhD, Xuejie Jiang, Duncan Mak, BSc, MPhil, Jonathan A. Pachter, PhD, David T. Weaver, PhD, Bing Xu, PhD, Michael Andreeff, MD PhD, Bing Z Carter, PhD

Blood (2016) 128 (22): 1574.

https://doi.org/10.1182/blood.V128.22.1574.1574

Published: 2016

Journal Articles

Results for Phase II Clinical Trial of LCL161, a SMAC Mimetic, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (post-ET MF)

Naveen Pemmaraju, MD, Bing Z Carter, PhD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Courtney D DiNardo, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Lingsha Zhou, Zeev Estrov, MD, Carla Kay Tuttle, RN, Karina Salinas, RN, Po Yee Mak, MPhil, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 3105.

https://doi.org/10.1182/blood.V128.22.3105.3105

Published: 2016

Journal Articles

Effects of CCL2/CCR2 Blockade in Acute Myeloid Leukemia

Rodrigo Omar Jacamo, PhD, Hong Mu, MD PhD, Qi Zhang, Dhruv Chachad, MS, Wang Zhiqiang, Wencai Ma, PhD, Min Zhang, MD PhD, Po Yee Mak, MPhil, Duncan Mak, BSc, MPhil, Peter Ruvolo, PhD, Teresa McQueen, Scott Lowe, Johannes Zuber, MD PhD, Dirk Eulberg, MBA, Anna Kruschinski, Marina Konopleva, MD PhD, R Eric Davis, MD, Michael Andreeff, MD PhD

Blood (2015) 126 (23): 1348.

https://doi.org/10.1182/blood.V126.23.1348.1348

Published: 2015

Journal Articles

Focal Adhesion Kinase As a Potential Target in AML and MDS

Bing Z Carter, Steven M. Kornblau, MD, Po Yee Mak, MPhil, Hui Yang, MD PhD, Yihua Qiu, MD, Xuejie Jiang, Kevin Coombes, PhD, Nianxiang Zhang, Guillermo Garcia-Manero, MD, Michael Andreeff, MD, PhD

Blood (2015) 126 (23): 3680.

https://doi.org/10.1182/blood.V126.23.3680.3680

Published: 2015

Journal Articles

Concurrent Inhibition of Beta-Catenin/CBP and FLT3 Strongly Suppresses c-Myc and Synergistically Induces Apoptosis in FLT3 Mutant AML Cells

Xuejie Jiang, Po Yee Mak, MPhil, Hong Mu, MD PhD, Weiguo Zhang, MD, PhD, Duncan Mak, BSc, MPhil, Peter Ruvolo, PhD, Teresa McQueen, Hongsheng Zhou, Jorge E. Cortes, Michael Andreeff, MD, PhD, Bing Z Carter

Blood (2015) 126 (23): 3685.

https://doi.org/10.1182/blood.V126.23.3685.3685

Published: 2015

Journal Articles

Synergistic Effects of Combined Targeting of Beta-Catenin/CBP and Bcr-Abl in CML Blast Crisis Stem/Progenitor Cells in Vitro and in Vivo as Analyzed By Single Cell Mass Cytometry (CyTOF)

Hongsheng Zhou, MD, Po Yee Mak, MPhil, Hong Mu, MD PhD, Duncan Mak, BSc, MPhil, Zhihong Zeng, MD, Jorge Cortes, MD, Michael Andreeff, MD PhD, Bing Z Carter

Blood (2015) 126 (23): 1566.

https://doi.org/10.1182/blood.V126.23.1566.1566

Published: 2015

NARROW

Disruption of Wnt/β-Catenin Signaling Exerts Antileukemia Activity and Sensitizes with Tyrosine Kinase Inhibitors in FLT3 Mutated AML In Vivo

Inhibition of FAK Exerts Anti-Leukemic Activity and Potentiates ABT-199-Induced Apoptosis in AML

Results for Phase II Clinical Trial of LCL161, a SMAC Mimetic, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (post-ET MF)

Effects of CCL2/CCR2 Blockade in Acute Myeloid Leukemia

Focal Adhesion Kinase As a Potential Target in AML and MDS

Concurrent Inhibition of Beta-Catenin/CBP and FLT3 Strongly Suppresses c-Myc and Synergistically Induces Apoptosis in FLT3 Mutant AML Cells

Synergistic Effects of Combined Targeting of Beta-Catenin/CBP and Bcr-Abl in CML Blast Crisis Stem/Progenitor Cells in Vitro and in Vivo as Analyzed By Single Cell Mass Cytometry (CyTOF)

Email alerts

ASH Publications

American Society of Hematology

Disruption of Wnt/β-Catenin Signaling Exerts Antileukemia Activity and Sensitizes with Tyrosine Kinase Inhibitors in FLT3 Mutated AML In Vivo

Inhibition of FAK Exerts Anti-Leukemic Activity and Potentiates ABT-199-Induced Apoptosis in AML

Results for Phase II Clinical Trial of LCL161, a SMAC Mimetic, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (post-ET MF)

Effects of CCL2/CCR2 Blockade in Acute Myeloid Leukemia

Focal Adhesion Kinase As a Potential Target in AML and MDS

Concurrent Inhibition of Beta-Catenin/CBP and FLT3 Strongly Suppresses c-Myc and Synergistically Induces Apoptosis in FLT3 Mutant AML Cells

Synergistic Effects of Combined Targeting of Beta-Catenin/CBP and Bcr-Abl in CML Blast Crisis Stem/Progenitor Cells in Vitro and in Vivo as Analyzed By Single Cell Mass Cytometry (CyTOF)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only